United States · FDA National Drug Code directory
Lidoxi
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87239-1111_513c517e-c099-02aa-e063-6294a90ac8a4
- Product NDC
- 87239-1111
- Form
- OINTMENT
- Composition / generic term
- Lidocaine
- Labeler
- T&T Pharma Holdings LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20260507
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE — .04 g/g
These values do not establish equivalence or a dose recommendation.
Packages
- 92 g in 1 TUBE, WITH APPLICATOR (87239-1111-1) · 87239-1111-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →